NEO (NeoGenomics) Cyclically Adjusted Book per Share: $6.56 (As of Mar. 2026)


NEO NeoGenomics Inc NEO
71 GF Score
Price $14.11
GF Value $16.58
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is NeoGenomics Cyclically Adjusted Book per Share?

NeoGenomics NEO -0.42% 71 Cyclically Adjusted Book per Share is $6.56 as of Mar. 2026. GuruFocus rates NEO with a GF Score™ of 71/100 and a GF Value™ of $16.58 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

NeoGenomics's adjusted book value per share for the three months ended in Mar. 2026 was $6.392. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6.56 for the trailing ten years ended in Mar. 2026.

During the past 12 months, NeoGenomics's average Cyclically Adjusted Book Growth Rate was 9.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 23.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 34.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of NeoGenomics was 75.00% per year. The lowest was 15.40% per year. And the median was 40.95% per year.

As of today (2026-06-29), NeoGenomics's current stock price is $14.11. NeoGenomics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $6.56. NeoGenomics's Cyclically Adjusted PB Ratio of today is 2.15.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of NeoGenomics was 28.25. The lowest was 0.84. And the median was 11.61.


NeoGenomics  (NAS:NEO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

NeoGenomics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=14.11/6.56
=2.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of NeoGenomics was 28.25. The lowest was 0.84. And the median was 11.61.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


NeoGenomics Cyclically Adjusted Book per Share Related Terms


NeoGenomics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for NeoGenomics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics Cyclically Adjusted Book per Share Chart

NeoGenomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.14 4.15 4.99 5.75 6.37

NeoGenomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.97 6.15 6.32 6.37 6.56

NEO vs WGS, CDNA, PSNL: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, NeoGenomics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoGenomics Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NeoGenomics's Cyclically Adjusted PB Ratio falls into.


NEO
71GF Score
NeoGenomics Inc NEO
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeoGenomics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NeoGenomics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.392/330.2130*330.2130
=6.392

Current CPI (Mar. 2026) = 330.2130.

NeoGenomics Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.615 241.018 3.583
201609 2.558 241.428 3.499
201612 2.084 241.432 2.850
201703 2.128 243.801 2.882
201706 2.129 244.955 2.870
201709 2.110 246.819 2.823
201712 2.137 246.524 2.862
201803 2.142 249.554 2.834
201806 2.012 251.989 2.637
201809 3.265 252.439 4.271
201812 3.392 251.233 4.458
201903 3.398 254.202 4.414
201906 4.717 256.143 6.081
201909 4.772 256.759 6.137
201912 4.843 256.974 6.223
202003 4.792 258.115 6.131
202006 5.926 257.797 7.591
202009 6.003 260.280 7.616
202012 6.195 260.474 7.854
202103 7.203 264.877 8.980
202106 9.358 271.696 11.373
202109 9.230 274.310 11.111
202112 8.930 278.802 10.577
202203 8.619 287.504 9.899
202206 8.303 296.311 9.253
202209 8.004 296.808 8.905
202212 7.864 296.797 8.749
202303 7.661 301.836 8.381
202306 7.521 305.109 8.140
202309 7.445 307.789 7.987
202312 7.392 306.746 7.958
202403 7.246 312.332 7.661
202406 7.164 314.175 7.530
202409 7.092 315.301 7.427
202412 7.042 315.605 7.368
202503 6.920 319.799 7.145
202506 6.637 322.561 6.794
202509 6.504 324.800 6.612
202512 6.486 324.054 6.609
202603 6.392 330.213 6.392

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $6.56 mean?
NeoGenomics (NEO) has a Cyclically Adjusted Book per Share of $6.56 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NeoGenomics and its competitors.
Is NeoGenomics' Cyclically Adjusted Book per Share too high?
NeoGenomics' current Cyclically Adjusted Book per Share is $6.56. Overall, NeoGenomics has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NeoGenomics' Cyclically Adjusted Book per Share compare to WGS and CDNA?
NeoGenomics' Cyclically Adjusted Book per Share of $6.56 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NeoGenomics and its competitors. NeoGenomics's current Cyclically Adjusted Book per Share is $6.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoGenomics stock overvalued right now?
Based on GuruFocus' analysis, NeoGenomics (NEO) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.58, compared to a current price of $14.11 — trading 14.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is $6.56. NeoGenomics' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For NeoGenomics (NEO), the current Cyclically Adjusted Book per Share is $6.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeoGenomics (NEO) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of $14.11 is trading 14.9% below its estimated GF Value™ of $16.58. GuruFocus considers NeoGenomics to be Modestly Undervalued.

Key valuation signals for NEO:

  • Cyclically Adjusted Book per Share: $6.56
  • GF Value™: $16.58 vs. price of $14.11 (14.9% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the NEO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NeoGenomics Business Description

Other Exchanges NEO:MexicoNG9:Germany
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
71GF Score

Get the complete analysis for NEO

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.11
Price
$16.58
GF Value